CME Stock Overview
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.
CME Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$192.11|
|52 Week High||US$256.94|
|52 Week Low||US$185.79|
|1 Month Change||-13.82%|
|3 Month Change||-18.81%|
|1 Year Change||-11.79%|
|3 Year Change||2.23%|
|5 Year Change||62.83%|
|Change since IPO||2,139.05%|
Recent News & Updates
Why CME Should Be In Our Dividend Growth Portfolios
CME Group is a great mix between growth and value as it offers a good yield and long-term (expected) outperformance. Because of its business model, the company is able to generate high free cash flow used to distribute a high yield as its healthy balance sheet needs no attention. The valuation is getting good, and I'm planning on using market weakness to add it to my dividend growth portfolio.
Is Now The Time To Put CME Group (NASDAQ:CME) On Your Watchlist?
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
|CME||US Capital Markets||US Market|
Return vs Industry: CME exceeded the US Capital Markets industry which returned -14.6% over the past year.
Return vs Market: CME exceeded the US Market which returned -12.9% over the past year.
|CME Average Weekly Movement||4.6%|
|Capital Markets Industry Average Movement||0.5%|
|Market Average Movement||7.8%|
|10% most volatile stocks in US Market||16.8%|
|10% least volatile stocks in US Market||2.9%|
Stable Share Price: CME is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: CME's weekly volatility (5%) has been stable over the past year.
About the Company
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services.
CME Group Fundamentals Summary
|CME fundamental statistics|
Is CME overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CME income statement (TTM)|
|Cost of Revenue||US$0|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||7.64|
|Net Profit Margin||57.51%|
How did CME perform over the long term?See historical performance and comparison
3.8%Current Dividend Yield
Does CME pay a reliable dividends?See CME dividend history and benchmarks
|CME Group dividend dates|
|Ex Dividend Date||Jun 09 2022|
|Dividend Pay Date||Jun 27 2022|
|Days until Ex dividend||17 days|
|Days until Dividend pay date||35 days|
Does CME pay a reliable dividends?See CME dividend history and benchmarks
Is CME Group undervalued compared to its fair value and its price relative to the market?
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CME ($192.11) is trading above our estimate of fair value ($181.59)
Significantly Below Fair Value: CME is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CME is good value based on its PE Ratio (25.2x) compared to the US Capital Markets industry average (30.8x).
PE vs Market: CME is poor value based on its PE Ratio (25.2x) compared to the US market (15.2x).
Price to Earnings Growth Ratio
PEG Ratio: CME is poor value based on its PEG Ratio (3.5x)
Price to Book Ratio
PB vs Industry: CME is overvalued based on its PB Ratio (2.5x) compared to the US Capital Markets industry average (-17.2x).
How is CME Group forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CME's forecast earnings growth (7.2% per year) is above the savings rate (1.9%).
Earnings vs Market: CME's earnings (7.2% per year) are forecast to grow slower than the US market (12.5% per year).
High Growth Earnings: CME's earnings are forecast to grow, but not significantly.
Revenue vs Market: CME's revenue (5.5% per year) is forecast to grow slower than the US market (7.8% per year).
High Growth Revenue: CME's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CME's Return on Equity is forecast to be low in 3 years time (10.9%).
How has CME Group performed over the past 5 years?
Past Performance Score3/6
Past Performance Score 3/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CME has high quality earnings.
Growing Profit Margin: CME's current net profit margins (57.5%) are higher than last year (41.6%).
Past Earnings Growth Analysis
Earnings Trend: CME's earnings have declined by 4.1% per year over the past 5 years.
Accelerating Growth: CME's earnings growth over the past year (43.4%) exceeds its 5-year average (-4.1% per year).
Earnings vs Industry: CME earnings growth over the past year (43.4%) underperformed the Capital Markets industry 98.3%.
Return on Equity
High ROE: CME's Return on Equity (10%) is considered low.
How is CME Group's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: CME's short term assets ($171.0B) exceed its short term liabilities ($168.5B).
Long Term Liabilities: CME's short term assets ($171.0B) exceed its long term liabilities ($9.7B).
Debt to Equity History and Analysis
Debt Level: CME's net debt to equity ratio (4.6%) is considered satisfactory.
Reducing Debt: CME's debt to equity ratio has increased from 10.9% to 12.4% over the past 5 years.
Debt Coverage: CME's debt is well covered by operating cash flow (75.6%).
Interest Coverage: CME earns more interest than it pays, so coverage of interest payments is not a concern.
What is CME Group current dividend yield, its reliability and sustainability?
Dividend Score 4/6
Future Dividend Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: CME's dividend (3.77%) is higher than the bottom 25% of dividend payers in the US market (1.58%).
High Dividend: CME's dividend (3.77%) is low compared to the top 25% of dividend payers in the US market (4.11%).
Stability and Growth of Payments
Stable Dividend: CME's dividend payments have been volatile in the past 10 years.
Growing Dividend: CME's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (48.3%), CME's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (105.2%), CME's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Terry Duffy (63 yo)
Mr. Terrence A. Duffy, also known as Terry, has been Chief Executive Officer and Chairman at CME Group Inc since November 15, 2016. Mr. Duffy is the Chief Executive Officer at New York Mercantile Exchange,...
CEO Compensation Analysis
Compensation vs Market: Terry's total compensation ($USD22.92M) is above average for companies of similar size in the US market ($USD13.34M).
Compensation vs Earnings: Terry's compensation has increased by more than 20% in the past year.
Experienced Management: CME's management team is seasoned and experienced (11.3 years average tenure).
Experienced Board: CME's board of directors are seasoned and experienced ( 17 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CME insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CME Group Inc.'s employee growth, exchange listings and data sources
- Name: CME Group Inc.
- Ticker: CME
- Exchange: NasdaqGS
- Founded: 1898
- Industry: Financial Exchanges and Data
- Sector: Diversified Financials
- Implied Market Cap: US$69.048b
- Shares outstanding: 359.42m
- Website: https://www.cmegroup.com
Number of Employees
- CME Group Inc.
- 20 South Wacker Drive
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/22 00:00|
|End of Day Share Price||2022/05/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.